S Kang, Y J Roh. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Angioid Streaks/complicationsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedChoroidal Neovascularization/drug therapyFemaleHumansImmunologic Factors/therapeutic useMiddle AgedRanibizumabTreatment OutcomeVisual Acuity
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedImmunologic FactorsRanibizumab
Year: 2009 PMID: 19590525 DOI: 10.1038/eye.2009.158
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 3.775